Results 171 to 180 of about 18,707 (219)
Some of the next articles are maybe not open access.
SNRIs: mechanism of action and clinical features
Expert Review of Neurotherapeutics, 2002Specific serotonin and norepinephrine reuptake inhibitors are a relatively recent class of antidepressants which have specificities making them a therapeutic choice. They are characterized by a mixed action on both major neuroamines of depression: norepinephrine and serotonin.
Olivier, Lambert, Michel, Bourin
openaire +2 more sources
A review of SSRIs and SNRIs in neuropathic pain
Expert Opinion on Pharmacotherapy, 2010Selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs) are becoming increasingly used in the treatment of neuropathic pain and fibromyalgia. However, they are not without adverse effects and their efficacy has not been clear because of conflicting evidence.We have examined the current evidence on the ...
Yee-Chi, Lee, Phoon-Ping, Chen
openaire +2 more sources
The anti-inflammatory mechanism of antidepressants – SSRIs, SNRIs
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2018The cytokine theory of depression no longer brings about any doubts. Experiments and research studies conducted in the last ten years have confirmed that both physical and psychological (emotional) stress increases the likelihood of occurrence of mental disorders (including depressive disorders) owing to the action of a series of hormonal and ...
Piotr, Gałecki +2 more
openaire +2 more sources
Fatal overdose with a combination of SNRIs venlafaxine and duloxetine
Forensic Science, Medicine and Pathology, 2019Drugs for the treatment of depressive disorders, including SNRIs (serotonin noradrenaline reuptake inhibitors) venlafaxine and duloxetine, are widely prescribed as they have a high therapeutic to toxicity ratio. In rare cases, adverse effects may be severe, usually due to iatrogenic, accidental or intentional self-overdose that cause the excessive ...
Armin, Alibegović +2 more
openaire +2 more sources
Effect of SSRIs and SNRIs on Nocturnal Urinary Frequency
Annals of Pharmacotherapy, 2016Background: Existing data suggest that selective serotonin uptake inhibitors (SSRIs) may have an impact on urinary frequency. Objective: To evaluate the impact of SSRIs and selective noradrenaline reuptake inhibitors (SNRIs) on nocturnal urinary frequency.
Boris I, Medarov +4 more
openaire +2 more sources
A Newly Released SNRI for Treatment of Fibromyalgia
Current Psychiatry Reports, 2010Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor (SNRI) that was recently approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM). SNRIs are frequently used, along with graded exercise and cognitive-behavioral therapy, to treat FM.
openaire +2 more sources
Treating Depression with SNRIs: Who Will Benefit Most?
CNS Spectrums, 2008AbstractThere is evidence that the serotonin norepinephrine reuptake inhibitors (SNRIs) venlafaxine, milnacipran, and duloxetine, have probable superior antidepressant activity to most selective serotonin reuptake inhibitors (SSRIs), especially in more severe depression. Some patients, however, respond better than others to SNRIs.
openaire +2 more sources
SSRIs vs. SNRIs for anxiety and OCD
The Brown University Child and Adolescent Behavior Letter, 2020Selective serotonin reuptake inhibitors (SSRIs) have greater adverse event (AE)–related discontinuation of treatment than serotonin‐norepinephrine reuptake inhibitors (SNRIs) in the treatment of pediatric obsessive‐compulsive disorder (OCD) and anxiety disorders. And SSRIs are more likely than SNRIs to produce “activation” (restlessness).
openaire +1 more source
Channelling of SSRIs and SNRIs use in the Tayside population, Scotland
Pharmacoepidemiology and Drug Safety, 2007AbstractPurposeTo compare the user profiles of the two classes of drug, using the Tayside Medicines Monitoring Unit (MEMO) record‐linkage database.MethodsA cohort study was carried out in the population of Tayside in Scotland. A total of 13 901 selective serotonin re‐uptake inhibitor (SSRI) users and 1417 selective norepinephrine re‐uptake inhibitor ...
Wei, Li +2 more
openaire +3 more sources
Pharmacological Profile of SSRIs and SNRIs in the Treatment of Eating Disorders
Current Clinical Pharmacology, 2009Bulimia Nervosa (BN) and Binge Eating Disorder (BED) are some of the most common eating disorders (ED) in industrialized societies, characterized by uncontrolled binge eating and self-induced purging or other compensatory behaviours aiming to prevent body weight gain.
CAPASSO, Anna, PETRELLA C, MILANO W.
openaire +3 more sources